Rockefeller Capital Management L.P. 10x Genomics, Inc. Transaction History
Rockefeller Capital Management L.P.
- $36.3 Billion
- Q3 2024
A detailed history of Rockefeller Capital Management L.P. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 17,504 shares of TXG stock, worth $272,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,504
Previous 12,758
37.2%
Holding current value
$272,712
Previous $248,000
59.27%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding TXG
# of Institutions
290Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$171 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$167 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$101 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$99.6 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$99.3 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.48B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...